PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic Alopecia-Combination Shows Superior Efficacy Dr. Garima Soni14 Oct 2025 12:31 PM ISTA Novel formulation of Minoxidil 5% and PRCT (Procapil, Redensyl, Caffeine, and Transcutol) has emerged superior in effectiveness, tolerability, and...
Can a Stevia-derived sweetener improve hair loss treatment? Dr. Kamal Kant Kohli13 Oct 2025 8:30 PM ISTAndrogenetic alopecia is a common form of hair loss in both men and women-also called male pattern baldness and female pattern hair loss. Topical...
Shampoo-Like Gel Could Help Chemo Patients Keep Their Hair, reports research Dr. Kamal Kant Kohli12 Oct 2025 8:15 PM ISTCancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel...
New imaging tech promises to help doctors better diagnose and treat skin cancers: Study Dr. Kamal Kant Kohli10 Oct 2025 8:45 PM ISTA University of Arizona research team will receive nearly $2.7 million from the NIH's Common Fund Venture Program to advance next-generation imaging...
Higher non-HDL to HDL cholesterol ratio Linked to Increased Psoriasis Risk: Study Jacinthlyn Sylvia10 Oct 2025 8:30 PM ISTA new study published in the journal of Experimental Dermatology revealed higher non-HDL to HDL cholesterol ratio (NHHR) is positively associated with...
Dupilumab use in Atopic Dermatitis may Reduce Risk of Otitis Media and Surgical Interventions: Study Dr Riya Dave9 Oct 2025 8:30 PM ISTAccording to a new study, Patients with atopic dermatitis (AD) treated with dupilumab have a lower risk of developing otitis media and needing related...
FDA Approves Oral Remibrutinib as First BTK Inhibitor for Chronic Spontaneous Urticaria Dr. Kamal Kant Kohli8 Oct 2025 8:45 PM ISTThe FDA has approved oral remibrutinib as the first BTK inhibitor for chronic spontaneous urticaria in adults not responding to...
FDA Approves Zoryve Cream for Young Children with Atopic Dermatitis Dr. Kamal Kant Kohli7 Oct 2025 10:00 PM ISTThe US Food and Drug Administration (FDA) has approved Zoryve (roflumilast) cream 0.05% for the topical treatment of mild to moderate atopic...
Patients with Allergies Face Elevated Risk of Developing Optic Neuritis: Study Shows Medha Baranwal7 Oct 2025 8:45 PM ISTSouth Korea: A new large-scale population-based study published in Scientific Reports has identified a noteworthy link between allergic diseases and...
Bimiralisib Gel Shows Strong Efficacy for Early-Stage Actinic Keratosis in Phase 2 trial Dr. Kamal Kant Kohli7 Oct 2025 7:30 AM ISTIn phase 2 results, bimiralisib gel 2% demonstrated high efficacy and tolerability in treating actinic keratosis, achieving a 92% response rate in...
Mediterranean Diet Eases Psoriasis Severity Independent of Weight Loss: JAMA Dr. Shravani Dali5 Oct 2025 8:15 PM ISTResearchers have found in a new randomized trial that adherence to a Mediterranean diet significantly reduced psoriasis severity in patients with mild...
Intralesional Triamcinolone Outperforms Methotrexate in Alopecia Areata, suggests research Jacinthlyn Sylvia3 Oct 2025 8:15 PM ISTA new clinical study published in the Journal of Cosmetic Dermatology revealed in a head-to-head trial that intralesional triamcinolone led to...
